Beacon Biosignals is dedicated to transforming precision medicine for brain-related conditions through its innovative at-home EEG platform. The company specializes in the clinical development of novel therapeutics for neurological, psychiatric, and sleep disorders, utilizing its FDA 510(k)-cleared Dreem EEG headband and advanced AI algorithms for quantitative biomarker discovery. With a vast Clinico-EEG database comprising data from nearly 100,000 patients, Beacon's cloud-native analytics platform facilitates large-scale retrospective and predictive studies. The organization is committed to enhancing patient treatment for disorders affecting brain physiology, while fostering a collaborative and quality-driven work environment that supports remote and in-person work options.